Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease

被引:1
|
作者
Vieira, Sophia R. L. [1 ]
Mezabrovschi, Roxana [1 ]
Toffoli, Marco [1 ]
Del Pozo, Sara Lucas [1 ]
Menozzi, Elisa [1 ]
Mullin, Stephen [1 ,2 ]
Yalkic, Selen [1 ]
Limbachiya, Naomi [1 ]
Koletsi, Sofia [1 ,3 ]
Loefflad, Nadine [1 ]
Lopez, Grisel J. [4 ]
Gan-Or, Ziv [5 ,6 ]
Alcalay, Roy N. [7 ,8 ]
Sidransky, Ellen [3 ,4 ]
Schapira, Anthony H. V. [1 ,3 ]
机构
[1] Univ Coll London Queen Sq, Dept Clin & Movement Neurosci, Inst Neurol, London, England
[2] Univ Plymouth, Fac Hlth, Plymouth, England
[3] Aligning Sci Parkinsons Collaborat Res Network, Chevy Chase, MD USA
[4] Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA
[5] McGill Univ, Neuro Montreal Neurol Inst Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada
[6] McGill Univ, Dept Human Genet, Montreal, PQ, Canada
[7] Columbia Univ, Irving Med Ctr, New York, NY USA
[8] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Tel Aviv Sch Med, Tel Aviv, Israel
关键词
GBA1; Parkinson's; counseling; neurodegeneration; risk; GLUCOCEREBROSIDASE MUTATIONS; GAUCHER-DISEASE; ASSOCIATION; RISK; MULTICENTER; PROGRESSION; DEMENTIA; POLYMORPHISM; SURVIVAL; MOTOR;
D O I
10.1002/mds.30006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glucocerebrosidase (GBA1) variants constitute numerically the most common known genetic risk factor for Parkinson's disease (PD) and are distributed worldwide. Access to GBA1 genotyping varies across the world and even regionally within countries. Guidelines for GBA1 variant counseling are evolving. We review the current knowledge of the link between GBA1 and PD, and discuss the practicalities of GBA1 testing. Lastly, we provide a consensus for an approach to counseling people with GBA1 variants, notably the communication of PD risk. (c) 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
引用
收藏
页码:2144 / 2154
页数:11
相关论文
共 50 条
  • [31] Revisiting the diagnosis of Gaucher disease in a family with multiple GBA1 variants
    Ryan, Emory
    Tayebi, Nahid
    D'Souza, Andrea
    Lopez, Grisel
    Lichtenberg, Jens
    Sidransky, Ellen
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2023, 191 (10) : 2647 - 2650
  • [32] Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
    Smith, Laura J.
    Lee, Chiao-Yin
    Menozzi, Elisa
    Schapira, Anthony H. V.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [33] Effects Of GBA1 Mutations and STN-DBS On Response Inhibition in Parkinson's Disease
    Almelegy, A.
    Gunda, S.
    Buyske, S.
    Rosenbaum, M.
    Sani, S.
    Afshari, M.
    Metman, L.
    Goetz, C.
    Hall, D.
    Mouradian, M.
    Pal, G.
    MOVEMENT DISORDERS, 2023, 38 : S743 - S744
  • [34] Expanding Views of Mitochondria in Parkinson’s Disease: Focusing on PINK1 and GBA1 Mutations
    Yu Yuan
    Xizhen Ma
    Ning Song
    Junxia Xie
    Neuroscience Bulletin, 2022, 38 : 825 - 828
  • [35] Expanding Views of Mitochondria in Parkinson's Disease: Focusing on PINK1 and GBA1 Mutations
    Yuan, Yu
    Ma, Xizhen
    Song, Ning
    Xie, Junxia
    NEUROSCIENCE BULLETIN, 2022, 38 (7) : 825 - 828
  • [36] Sex distribution and classification of GBA1 variants in an Italian cohort of Parkinson's disease patients analyzed over the last seventeen years
    Panteghini, Celeste
    Reale, Chiara
    Colangelo, Isabel
    Suerz, Marta
    Catania, Alessia
    Garavaglia, Barbara
    Invernizzi, Federica
    PARKINSONISM & RELATED DISORDERS, 2023, 117
  • [37] Lack of full sequencing GBA1 studies for patients with Parkinson's disease in Latin America
    Lopes Santos-Lobato, Bruno
    Schumacher-Schuh, Artur F.
    Mata, Ignacio F.
    NPJ PARKINSONS DISEASE, 2022, 8 (01)
  • [38] Lack of full sequencing GBA1 studies for patients with Parkinson’s disease in Latin America
    Bruno Lopes Santos-Lobato
    Artur F. Schumacher-Schuh
    Ignacio F. Mata
    npj Parkinson's Disease, 8
  • [39] Contrasting Olfactory Perception in Parkinson's disease (PD): Impact of GBA1 Gene Mutations
    Schechter, Y.
    Dominko, M.
    Cohen, M.
    Yahalom, G.
    Zimran, A.
    Revel-Vilk, S.
    Shulman, E.
    Dinur, T.
    Cohen, M. Becker
    MOVEMENT DISORDERS, 2024, 39 : S140 - S140
  • [40] Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?
    Surface, Matthew
    Balwani, Manisha
    Waters, Cheryl
    Haimovich, Alexander
    Gan-Or, Ziv
    Marder, Karen S.
    Hsieh, Tammy
    Song, Linxia
    Padmanabhan, Shalini
    Hsieh, Frank
    Merchant, Kalpana M.
    Alcalay, Roy N.
    MOVEMENT DISORDERS, 2022, 37 (08) : 1782 - 1782